<<I view TH-302 as an appreciating asset which will just become more valuable with each new piece of data - which will make it more and more obvious that the drug is safe and has substantial efficacy,>>
This assumes, of course, that the drug is in fact safe and efficacious. It is possible that it is not and that a piece of data will be released that will show the opposite.